Story perspectives

Scripps Implements Poison Pill to Thwart Sinclair's Takeover

12/2/2025

Summary

Story summary

E.W. Scripps Co. adopted a poison pill to block Sinclair Inc.'s unsolicited offer, allowing shareholders to buy additional stock at a discount if an unapproved party pursues control.
The defensive measure aims to ensure shareholders receive fair value and gives Scripps time to evaluate the proposal.
Sinclair Inc., which already owns 9.9% of Scripps, argues that the merger is strategically beneficial.
Scripps' stock rose after the rights plan was announced.

1 of 1

Story summary

E.W. Scripps Co. adopted a poison pill to block Sinclair Inc.'s unsolicited offer, allowing shareholders to buy additional stock at a discount if an unapproved party pursues control.
The defensive measure aims to ensure shareholders receive fair value and gives Scripps time to evaluate the proposal.
Sinclair Inc., which already owns 9.9% of Scripps, argues that the merger is strategically beneficial.
Scripps' stock rose after the rights plan was announced.